{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-117526","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2022-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.415000+00:00","generated_at":"2026-06-26T05:06:52.871877+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"GoodRx appoints Romin Nabiey as Chief Accounting Officer","bullets":["Appointment effective April 20, 2022; Nabiey becomes principal accounting officer.","Nabiey succeeds CFO Karsten Voermann, who remains principal financial officer.","Nabiey has served at GoodRx since May 2017, most recently as SVP, Corporate Controller.","No new compensation has been determined for Nabiey in connection with the appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-117526","json":"https://secwatch.observer/filing/0001193125-22-117526.json","markdown":"https://secwatch.observer/filing/0001193125-22-117526.md","text":"https://secwatch.observer/filing/0001193125-22-117526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000119312522117526/0001193125-22-117526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000119312522117526/d200437d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T05:06:52.871877+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1fd940183c","claim":"Romin Nabiey was appointed as Chief Accounting Officer at GoodRx Holdings, Inc..","evidence_excerpt":"On April 20, 2022, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) appointed Romin Nabiey, Senior Vice President, Corporate Controller of the Company as the Company’s Chief Accounting Officer and designated Mr. Nabiey as the principal accounting officer of the Company, in each case effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000119312522117526/0001193125-22-117526-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"b97f796c42","claim":"Karsten Voermann changed role as Chief Financial Officer at GoodRx Holdings, Inc..","evidence_excerpt":"Mr. Nabiey succeeds Karsten Voermann, the Company’s Chief Financial Officer, in such role.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000119312522117526/0001193125-22-117526-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"succeeded"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}